Teva Takeda Pharma Ltd. clinical trials
Formerly part of Teva Pharmaceutical Industries, Ltd., Mar 31, 2025 · source ↗
The registry lists 1 studies whose lead sponsor is Teva Takeda Pharma Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 13, 2024.
- 1study on the registry
- 0open to participants now
Before and after it left Teva Pharmaceutical Industries, Ltd.
- First submitted before Teva Takeda Pharma Ltd. left Teva Pharmaceutical Industries, Ltd.
- 1
- First submitted after Teva Takeda Pharma Ltd. left Teva Pharmaceutical Industries, Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Where
- Japan1
Over the years
- 115
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Teva Takeda Pharma Ltd.1 study
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Teva Pharmaceutical Industries, Ltd. studies →
- Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"CompletedNCT03209479
Sponsor listed in the registry: Teva Takeda Pharma Ltd. · First submitted before Teva Takeda Pharma Ltd. left Teva Pharmaceutical Industries, Ltd.